Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 169   

Articles published

GSK 1,560.00 -11.00 (-0.70%)
price chart
3 Reasons I Believe GlaxoSmithKline plc Is One Step Ahead Of AstraZeneca plc
Back in 2012, AstraZeneca (LSE: AZN) (NYSE: AZN.US) was priced for disaster. Investors expected the firm's profits to fall off the patent cliff, and the firm's shares were trading on a trailing P/E of around 6 times earnings, with a yield of more than 6%.
Here's Why The Market Hates GlaxoSmithKline plc, But Loves Shire plc
GlaxoSmithKline (LSE: GSK) rose modestly this week following upbeat quarterly results and news that the drugs maker was considering a spin-out of ViiV Healthcare, its HIV medicines business.
Glaxo Posts Sharp Fall in Profit  Wall Street Journal
UPDATE: Glaxo Pretax Profit Down, Confirms GBP4 Billion Cash Return  London South East
Should You Really Sell GlaxoSmithKline plc And National Grid plc?
However, downgrades from City analysts in recent months have left both companies with more �sell� than �buy� recommendations.
GlaxoSmithKline plc to Issue Quarterly Dividend of $0.70 on April 9th (GSK)  Dakota Financial News
Are Dividends Built To Last At GlaxoSmithKline plc And BHP Billiton plc?
Under the spotlight today, two FTSE 100 giants: GlaxoSmithKline (LSE: GSK) the pharmaceutical provider and BHP Billiton (LSE: BLT) the diversified commodity producer.
GlaxoSmithKline plc Rating Reiterated by Goldman Sachs (GSK)
GlaxoSmithKline plc (NYSE:GSK)'s stock had its �buy� rating reissued by research analysts at Goldman Sachs in a report released on Tuesday.
GlaxoSmithKline plc Receives Consensus Recommendation of "Hold" ...  The Legacy
GlaxoSmithKline plc Receives "Buy" Rating from Goldman Sachs (GSK)  sleekmoney
How Safe Are GlaxoSmithKline plc And AstraZeneca plc's Dividends?
GlaxoSmithKline has actually kept its dividend growing, but back in 2010 it wasn't covered by earnings. And though 2011 got things back on track, falling earnings for the next three years took cover down to just 1.2 times -- and there's cover of only 1 ...
GlaxoSmithKline plc Receives $46.00 Average Price Target from Analysts ...
GlaxoSmithKline plc logo Shares of GlaxoSmithKline plc (NYSE:GSK) have been given an average recommendation of �Hold� by the twenty-two ratings firms that are currently covering the stock, American Banking and Market News reports.
GlaxoSmithKline plc Earns Buy Rating from Goldman Sachs (GSK)
Goldman Sachs reaffirmed their buy rating on shares of GlaxoSmithKline plc (LON:GSK) in a report issued on Tuesday. They currently have a GBX 1,670 ($25.74) target price on the stock.
190 Million Reasons To Buy GlaxoSmithKline plc
Like the rest of the pharmaceuticals sector, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been taking increasingly-aggressive measures to hammer its product pipeline back into shape and counter the relentless trend of patent losses across its ...
GlaxoSmithKline plc Rating Reiterated by Beaufort Securities (GSK)
GlaxoSmithKline plc (NYSE:GSK) traded down 0.69% on Tuesday, hitting $47.60. The stock had a trading volume of 1,850,334 shares.